P
Platinum Cryo
Request Full Data Access to the Medutest database of peptide tests.
Products examined
| Product | Rating | Samples | Avg | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Semaglutide | B | 6 | 6.1 | 5.2 | 8.0 | 22 Apr 2025 |
| Ipamorelin | C | 6 | 5.6 | 4.8 | 6.5 | 22 Apr 2025 |
| Retatrutide | C | 6 | 6.6 | 5.0 | 8.0 | 22 Apr 2025 |
| Melanotan II | E | 6 | 4.1 | 2.0 | 7.0 | 22 Apr 2025 |
| 1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 | X | 1 | 4.0 | 3.7 | 3.7 | 20 Jun 2025 |
| 17a-Methyl-1-Testosterone | X | 1 | 6.9 | 6.9 | 6.9 | 11 Jun 2025 |
| Andarine (S-4) Raw | X | 1 | 5.5 | 5.5 | 5.5 | 25 Apr 2025 |
| ARA-290 | X | 1 | 5.7 | 5.7 | 5.7 | 24 Apr 2025 |
| BPC-157 Arg Oral | B | 2 | 5.7 | 5.6 | 5.7 | 24 May 2026 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X | 1 | 4.0 | 2.0 | 2.0 | 13 Jun 2025 |
| Chonluten | X | 1 | 4.0 | 3.7 | 3.7 | 21 May 2025 |
| CJC-1295 w/o DAC 10mg + IPA 10mg Blend | B | 2 | 5.3 | 4.6 | 6.0 | 20 May 2026 |
| CJC-1295 w/o DAC 5mg + IPA 5mg Blend | B | 2 | 5.6 | 5.5 | 5.7 | 17 May 2026 |
| EPO | B | 2 | 7.2 | 6.0 | 8.3 | 21 May 2026 |
| Exemestane (Aromasin) Raw | B | 2 | 4.0 | 3.1 | 4.2 | 17 May 2026 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | B | 2 | 6.1 | 3.7 | 8.5 | 20 May 2026 |
| Methylene Blue | X | 1 | 7.6 | 7.6 | 7.6 | 28 Mar 2025 |
| N-Acetyl Epitalon Amidate | B | 2 | 5.0 | 4.4 | 5.6 | 25 May 2026 |
| NA Semax Amidate | B | 2 | 5.7 | 3.4 | 7.9 | 17 May 2026 |
| NAD+ | B | 2 | 4.0 | 3.5 | 4.4 | 23 May 2026 |
| Nitroethane CAS 79-24-3 | B | 2 | 7.0 | 6.5 | 7.4 | 24 May 2026 |
| P21 | B | 2 | 5.6 | 3.2 | 8.0 | 25 May 2026 |
| PE 22-28 | X | 1 | 8.7 | 8.7 | 8.7 | 25 Apr 2025 |
| Semax | X | 1 | 5.2 | 5.2 | 5.2 | 24 Apr 2025 |
| SNAP-8 | X | 1 | 4.0 | 3.3 | 3.3 | 21 May 2025 |
| Supertest 450 | X | 1 | 5.8 | 5.8 | 5.8 | 6 May 2025 |
| Tadalafil Raw | B | 2 | 5.0 | 4.4 | 5.5 | 17 May 2026 |
| Tirzepatide 30mg Pen Kit | X | 1 | 5.8 | 5.8 | 5.8 | 27 Feb 2025 |
| Vilon | B | 2 | 4.9 | 4.6 | 5.3 | 24 May 2026 |
| Winstrol (Stanozolol) | X | 1 | 6.1 | 6.1 | 6.1 | 11 Jun 2025 |
The certificates
| Date | Product | Score | Declared | Measured | Deviation | Purity | Laboratory |
|---|---|---|---|---|---|---|---|
| 25 May 2026 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 5.1 | 20mg | 22.6mg | +12.9% | 97.06% | Lab G |
| 25 May 2026 | Exemestane (Aromasin) Raw | 4.8 | 5g | 4.5g | -10.1% | 99.26% | Lab D |
| 25 May 2026 | P21 | 4.8 | 10mg | 11.1mg | +11.3% | 96.92% | Lab A |
| 24 May 2026 | Chonluten | 4.0 | 2mg | 1.8mg | -11.1% | 96.56% | Lab F |
| 24 May 2026 | Supertest 450 | 4.0 | 100mg/ml | 111.5mg/ml | +11.5% | 95.55% | Lab A |
| 24 May 2026 | Tadalafil Raw | 4.0 | 500g | 533.8g | +6.8% | 97.50% | Lab A |
| 24 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 5.0 | 10mg | 9.7mg | -2.9% | 96.27% | Lab C |
| 24 May 2026 | Methylene Blue | 7.5 | 25mg | 22.1mg | -11.6% | 97.63% | Lab A |
| 23 May 2026 | BPC-157 Arg Oral | 5.6 | 25mg | 28.5mg | +13.9% | 95.11% | Lab C |
| 23 May 2026 | EPO | 6.9 | 5mg | 4.3mg | -14.0% | 99.67% | Lab F |
| 23 May 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 4.0 | 30mg | 31.2mg | +4.1% | 97.34% | Lab B |
| 23 May 2026 | Vilon | 5.1 | 2mg | 2.4mg | +19.6% | 99.18% | Lab G |
| 21 May 2026 | Nitroethane CAS 79-24-3 | 7.8 | 1g | 1.2g | +17.9% | 98.46% | Lab D |
| 20 May 2026 | NA Semax Amidate | 6.3 | 2mg | 2.0mg | -1.1% | 95.21% | Lab A |
| 19 May 2026 | BPC-157 Arg Oral | 5.2 | 50mg | 44.0mg | -11.9% | 98.71% | Lab G |
| 19 May 2026 | N-Acetyl Epitalon Amidate | 4.3 | 15mg | 13.2mg | -12.2% | 98.90% | Lab C |
| 19 May 2026 | NAD+ | 4.3 | 10mg | 9.4mg | -6.4% | 97.90% | Lab A |
| 17 May 2026 | 17a-Methyl-1-Testosterone | 6.8 | 50mg | 58.6mg | +17.2% | 96.36% | Lab G |
| 29 Jan 2026 | Nitroethane CAS 79-24-3 | 6.4 | 5g | 6.0g | +20.0% | 99.22% | Lab F |
| 26 Jan 2026 | Andarine (S-4) Raw | 6.7 | 5g | 4.4g | -11.5% | 99.24% | Lab G |
| 26 Jan 2026 | NAD+ | 4.0 | 30mg | 26.1mg | -13.1% | 95.80% | Lab B |
| 26 Jan 2026 | P21 | 4.4 | 5mg | 4.5mg | -9.7% | 97.88% | Lab G |
| 9 Jan 2026 | ARA-290 | 6.4 | 50mg | 42.9mg | -14.3% | 95.55% | Lab C |
| 7 Jan 2026 | CJC-1295 w/o DAC 10mg + IPA 10mg Blend | 6.2 | 10mg | 10.9mg | +9.2% | 98.02% | Lab F |
| 7 Jan 2026 | Tirzepatide 30mg Pen Kit | 5.7 | 5mg | 5.9mg | +18.1% | 98.92% | Lab F |
| 29 Dec 2025 | N-Acetyl Epitalon Amidate | 4.3 | 20mg | 23.4mg | +17.2% | 97.28% | Lab E |
| 12 Dec 2025 | CJC-1295 w/o DAC 5mg + IPA 5mg Blend | 6.1 | 10mg | 8.8mg | -11.8% | 95.79% | Lab E |
| 12 Dec 2025 | NA Semax Amidate | 7.3 | 20mg | 24.2mg | +20.9% | 98.90% | Lab A |
| 12 Dec 2025 | Semax | 4.0 | 50mg | 49.2mg | -1.6% | 98.06% | Lab A |
| 12 Dec 2025 | Winstrol (Stanozolol) | 4.7 | 20mg | 18.0mg | -10.0% | 97.07% | Lab G |
| 5 Dec 2025 | Cagrilintide 5mg + Semaglutide 5mg Blend | 4.0 | 20mg | 20.9mg | +4.6% | 97.97% | Lab F |
| 14 Nov 2025 | Exemestane (Aromasin) Raw | 4.3 | 5g | 4.9g | -2.4% | 95.32% | Lab G |
| 14 Nov 2025 | Vilon | 5.3 | 2mg | 2.2mg | +9.0% | 95.80% | Lab A |
| 5 Nov 2025 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 6.0 | 10mg | 9.7mg | -3.1% | 97.37% | Lab G |
| 5 Nov 2025 | PE 22-28 | 9.8 | 30mg | 31.8mg | +5.9% | 97.82% | Lab F |
| 17 Oct 2025 | 1-Boc-4-AP (tert-butyl 4-(phenylamino)piperidine-1-carboxylate) CAS 125541-22-2 | 4.0 | 5g | 5.8g | +16.7% | 99.12% | Lab C |
| 17 Oct 2025 | EPO | 6.9 | 20mg | 18.5mg | -7.7% | 95.14% | Lab C |
| 9 Oct 2025 | Tadalafil Raw | 4.9 | 1g | 1.2g | +23.5% | 96.47% | Lab E |
| 3 Oct 2025 | SNAP-8 | 4.4 | 15mg | 18.6mg | +24.1% | 95.42% | Lab B |
| 8 May 2025 | Melanotan II | 7.0 | 10mg | 9.79mg | -2.1% | 99.50% | Lab E |
| 8 May 2025 | Melanotan II | 2.2 | 10mg | 3.07mg | -69.3% | 98.81% | Lab E |
| 7 May 2025 | Ipamorelin | 5.4 | 5mg | 5.84mg | +16.8% | 100.00% | Lab E |
| 7 May 2025 | Semaglutide | 5.6 | 5mg | 5.05mg | +1.0% | 98.58% | Lab E |
| 7 May 2025 | Retatrutide | 5.0 | 15mg | 14.5mg | -3.3% | 97.30% | Lab E |
| 7 May 2025 | Retatrutide | 5.0 | 15mg | 14.3mg | -4.7% | 96.45% | Lab E |
| 7 May 2025 | Ipamorelin | 6.1 | 5mg | 5.36mg | +7.2% | 99.43% | Lab E |